MALAT1 was initially found to be significantly elevated in metastatic lung cancer cells [26], and studies have shown that it plays an important role in the angiogenic capacity, invasion, and apoptosis of tumor cells, which is a potential biomarker for tumor prediction and treatment [14]. Here, MALAT1 is linked to lung carcinoma.